GIGALANE Co.,Ltd. (KOSDAQ:049080)
2,600.00
+600.00 (30.00%)
At close: Apr 17, 2026
GIGALANE Revenue
In the year 2025, GIGALANE had annual revenue of 40.33B KRW, down -3.26%. GIGALANE had revenue of 14.01B in the quarter ending December 31, 2025, with 56.33% growth.
Revenue
40.33B
Revenue Growth
-3.26%
P/S Ratio
5.47
Revenue / Employee
226.58M
Employees
178
Market Cap
220.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 40.33B | -1.36B | -3.26% |
| Dec 31, 2024 | 41.69B | -2.60B | -5.88% |
| Dec 31, 2023 | 44.29B | -10.43B | -19.06% |
| Dec 31, 2022 | 54.73B | -16.90B | -23.59% |
| Dec 31, 2021 | 71.62B | 27.34B | 61.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| New Power Plasma | 577.99B |
| Avaco | 392.90B |
| C&G Hi Tech | 196.19B |
| JVM Co., Ltd. | 173.13B |
| HyVision System. | 171.10B |
| Keeps Biopharma | 170.15B |
| HB Technology CO.,LTD. | 160.31B |
| DMS Co.,Ltd. | 155.47B |